---
schema_version: "secwatch.filing_event.v1"
accession: "0000009326-25-000019"
form_type: "8-K"
ticker: "BCPC"
cik: "0000009326"
company_name: "BALCHEM CORP"
filed_at: "2025-10-21T23:59:59+00:00"
generated_at: "2026-05-17T03:10:22.640378+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Balchem Q3 2025: record sales $267.6M, adj. EPS $1.35, all segments grow

## Summary
- Record net sales $267.6M (+11.5% YoY); GAAP EPS $1.24 vs $1.03; adjusted EPS $1.35 vs $1.13.
- Record adjusted EBITDA $71.4M (+11.0% YoY); free cash flow $50.7M.
- All three segments achieved sales and earnings growth; new NY microencapsulation plant to double capacity.
- Net debt reduced to $88.9M, leverage 0.3x; repaid $36M on revolver during Q3.

## SEC filing metadata
- accession: 0000009326-25-000019
- form_type: 8-K
- ticker: BCPC
- cik: 0000009326
- company_name: BALCHEM CORP
- filed_at: 2025-10-21T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/9326/000000932625000019/0000009326-25-000019-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/9326/000000932625000019/bcpc-20251021.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000009326-25-000019
- JSON: https://secwatch.observer/filing/0000009326-25-000019.json
- Plain text: https://secwatch.observer/filing/0000009326-25-000019.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.